Bronchitis chronic and Oligohydramnios

Summary:

Oligohydramnios is found among people with Bronchitis chronic, especially for people who are female, 20-29 old.

The study analyzes which people have Oligohydramnios with Bronchitis chronic. It is created by eHealthMe based on reports of 15 people who have Bronchitis chronic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Bronchitis chronic?

Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic) is found to be associated with 566 drugs and 543 conditions by eHealthMe. Check the latest studies of Bronchitis chronic.

What is Oligohydramnios?

Oligohydramnios (a condition in pregnancy characterized by a deficiency of amniotic fluid) is found to be associated with 239 drugs and 435 conditions by eHealthMe. Check the latest studies of Oligohydramnios.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

15 people who have Bronchitis Chronic and Oligohydramnios are studied.

Would you have Oligohydramnios when you have Bronchitis chronic?

Gender of people who have Bronchitis Chronic and experienced Oligohydramnios *:

female: 100 %
male: 0.0 %

Age of people who have Bronchitis Chronic and experienced Oligohydramnios *:

Common co-existing conditions for these people *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 93.33%
Gastroduodenal Ulcer: 6 people, 40.00%

Common drugs taken by these people *:

Diclofenac: 14 people, 93.33%
Sulfasalazine: 3 people, 20.00%
Prednisolone: 3 people, 20.00%
Omeprazole: 3 people, 20.00%
Diclofenac Sodium And Misoprostol: 1 person, 6.67%

Common symptoms for these people *:

Maternal Exposure During Pregnancy (use of substance during pregnancy): 7 people, 46.67%
Hepatic Enzyme Increased: 6 people, 40.00%
Live Birth: 5 people, 33.33%
Premature Rupture Of Membranes: 3 people, 20.00%
Premature Delivery: 2 people, 13.33%
Tenosynovitis (inflammation of the fluid-filled sheath (called the synovium) that surrounds a tendon): 1 person, 6.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
Premature Labor: 1 person, 6.67%
Foetal Malposition (abnormal positions of the vertex of the fetal head relative to the maternal pelvis): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Oligohydramnios?

- Check whether Oligohydramnios is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Bronchitis chronic (8,477 reports)
Oligohydramnios (4,081 reports)

All the drugs that are associated with Oligohydramnios:

Oligohydramnios (239 drugs)

All the conditions that are associated with Oligohydramnios:

Oligohydramnios (435 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Oligohydramnios and Bronchitis chronic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.